Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are used in treating cardiovascular diseases. Previous studies indicated that ACEIs/ARBs may benefit cancer patients by inhibiting tumor angiogenesis and proliferation. The effect of ACEIs/ARBs on c...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Po-Chih, Huang, Ru-Yu, Yang, Yu-Chien, Hsieh, Kun-Pin, Yang, Yi-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022235/
https://www.ncbi.nlm.nih.gov/pubmed/35443635
http://dx.doi.org/10.1186/s12885-022-09513-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022235/
https://www.ncbi.nlm.nih.gov/pubmed/35443635
http://dx.doi.org/10.1186/s12885-022-09513-4

Ejemplares similares